DR. CYRUS PARSE ZABETIAN, MD
Neurology in Seattle, WA

License number
Washington MD00035514
Category
Neurology
Type
Neurology
Address
Address
1660 S Columbian Way Grecc (S-182), Seattle, WA 98108
Phone
(206) 277-6167
(206) 764-2569 (Fax)

Personal information

See more information about CYRUS PARSE ZABETIAN at radaris.com
Name
Address
Phone
Cyrus Zabetian, age 59
9738 Waters Ave S, Seattle, WA 98118
(206) 674-9574
Cyrus Zabetian
Seattle, WA
(206) 674-9574
Cyrus P Zabetian, age 59
6816 25Th Ave NE, Seattle, WA 98115
(206) 527-8685
Cyrus P Zabetian, age 59
6816 25Th St, Seattle, WA 98115
(206) 527-8685
Cyrus P Zabetian, age 59
9738 Waters Ave, Seattle, WA 98118
(206) 674-9574

Professional information

Cyrus Parse Zabetian Photo 1

Cyrus Parse Zabetian, Seattle WA

Specialties:
Neurology
Work:
Veterans Affairs Puget Sound Health Care Center
1660 S Columbian Way, Seattle, WA 98108
Education:
University of Miami(1994)


Cyrus P Zabetian Photo 2

Dr. Cyrus P Zabetian - MD (Doctor of Medicine)

Hospitals:
1660 S Columbian Way, Seattle 98108
1660 S Columbian Way, Seattle 98108
Education:
Medical Schools
University of Miami / School of Medicine
Graduated: 1994


Cyrus Zabetian Photo 3

Method Of Identifying And Treating A Person Having A Predisposition To Or Afflicted With Parkinson Disease

US Patent:
2013032, Dec 5, 2013
Filed:
Oct 19, 2012
Appl. No.:
13/574000
Inventors:
Haydeh Payami - Slingerlands NY, US
Taye H. Hamza - Albany NY, US
Stewart A. Factor - Atlanta GA, US
John Nutt - Portland OR, US
Cyrus Zabetian - Seattle WA, US
Honglei Chen - Cary NC, US
Erin Hill Burns - Niskayuna NY, US
Assignee:
Health Research Inc. - Menands NY
Emory University School of Medicine - Atlanta GA
National Institute of Environmental Health Sciences - Research Triangle Park NC
Veterans Affairs Puget Sound Health Care System - Seattle WA
Oregon Health & Science University - Portland OR
International Classification:
C12Q 1/68, A61K 31/465, A61K 31/522, A61K 45/06
US Classification:
514165, 514343, 51426334, 514570, 514420, 514682, 514605, 514413, 514569, 514567, 514378, 514406, 544274, 5462794, 435 611
Abstract:
The present invention relates to methods of treatment for Parkinson Disease (PD) in a person by identifying gene variants which may indicate a more favorable response to specific medicaments, thereby allowing for personalized or individualized treatment. The present invention relates to a method of screening for a genetic predisposition to PD in a person. The present invention is also directed to a method of testing a person for the presence of particular gene variants, wherein the presence of a gene variant indicates a higher predisposition to PD, and the absence of a gene variant indicates a lower predisposition to PD, compared to a control sample. The present invention further relates to methods and kits for treating, or inhibiting the development of, PD in a person. The present invention is also directed to a method of identifying the heritage of an individual based on the genetic profile of the individual.